HighVista Strategies’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.87M Sell
58,643
-55,921
-49% -$3.55M 1.07% 21
2025
Q4
$7.28M Sell
114,564
-18,366
-14% -$1.14M 1.87% 9
2025
Q3
$7.31M Buy
132,930
+64,278
+94% +$2.65M 1.79% 11
2025
Q2
$2.27M Buy
68,652
+23,903
+53% +$831K 0.83% 34
2025
Q1
$1.8M Buy
44,749
+30,488
+214% +$1.4M 0.69% 51
2024
Q4
$671K Buy
14,261
+4,206
+42% +$218K 0.25% 118
2024
Q3
$531K Buy
+10,055
New +$560K 0.18% 126
2022
Q4
Sell
-73,154
Closed -$3.54M 109
2022
Q3
$3.54M Buy
73,154
+5,652
+8% +$272K 2.02% 12
2022
Q2
$2.65M Buy
67,502
+1,733
+3% +$69.8K 1.6% 19
2022
Q1
$2.42M Buy
65,769
+30,537
+87% +$1.09M 1.54% 18
2021
Q4
$1.61M Buy
+35,232
New +$1.36M 1.28% 19
2021
Q1
Sell
-47,520
Closed -$987K 130
2020
Q4
$987K Buy
+47,520
New +$868K 0.63% 27

Other funds holding CYTK